Who is the CEO of DMAC? | Glauxie AI

Q: Who is the CEO of DMAC?

DiaMedica Therapeutics Inc. (DMAC) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Dietrich John Pauls. DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human... Employees: 35.

Q: What does DMAC company do?

Learn what DMAC does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling DMAC?

Track recent insider buys and sells for DMAC with transaction details, amounts, and trends.

Q: What sector is DMAC in?

Find DMAC sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of DMAC?

🦉

DiaMedica Therapeutics Inc. (DMAC)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODietrich John Pauls

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate...

Key Executives

Name	Title
Ambarish Shah	Chief Technology Officer
Dietrich John Pauls	President, Chief Executive Officer & Director
Dominic R. Cundari	Chief Commercial Officer
Julie Krop	Chief Medical Officer
Scott Kellen	Chief Financial Officer & Corporate Secretary

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

DMAC Profile Financials

What does DMAC company do? Are insiders buying or selling DMAC? What sector is DMAC in?